Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

Issued Date

2022-01-15

Resource Type

Letter

ISSN

01406736

eISSN

1474547X

DOI

10.1016/S0140-6736(21)02844-0

Scopus ID

2-s2.0-85122668243

Pubmed ID

34942101

Journal Title

The Lancet

Volume

399

Issue

10321

Start Page

234

End Page

236

Rights Holder(s)

SCOPUS

Bibliographic Citation

The Lancet Vol.399 No.10321 (2022) , 234-236

Suggested Citation

Dejnirattisai W. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. The Lancet Vol.399 No.10321 (2022) , 234-236. 236. doi:10.1016/S0140-6736(21)02844-0 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/87388

Title

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

Author(s)

Dejnirattisai W.

Author's Affiliation

Siriraj Hospital
 Oxford University Hospitals NHS Foundation Trust
 Diamond Light Source
 The Wellcome Centre for Human Genetics
 University of Nottingham Medical School
 University of Oxford
 Nuffield Department of Medicine
 University of Oxford Medical Sciences Division
 Oxford House

Other Contributor(s)

Mahidol University

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/87388

Collections

Scopus 2022